Why Nordson Shares Are Trading Higher By Over 5%; Here Are 20 Stocks Moving Premarket

Benzinga · 08/21 09:23
Shares of Nordson Corporation (NASDAQ:NDSN) rose sharply in pre-market trading after the company reported better-than-expected third-quarter results.
The precision dispensing equipment manufacturer reported third-quarter revenue of $741.51 million, beating analyst estimates of $722.57 million. Adjusted earnings per share came in at $2.73, surpassing the $2.63 consensus estimate. N
Nordson shares jumped 5.4% to $225.10 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
Gainers
- Aethlon Medical, Inc. (NASDAQ:AEMD) climbed 68.2% to $1.87 in pre-market trading. Aethlon Medical filed for offering of common stock and accompanying warrants.
- Tharimmune, Inc. (NASDAQ:THAR) shares gained 53.8% to $5.52 in pre-market trading. Tharimmune announced positive pharmacokinetic simulation results for its lead drug candidate TH104, designed to prevent respiratory depression from fentanyl exposure.
- Youlife Group Inc. (NASDAQ:YOUL) gained 38.8% to $2.09 in pre-market trading after declining 8% on Wednesday.
- Brazil Potash Corp. (NYSE:GRO) gained 35.8% to $2.05 in pre-market trading. Brazil Potash announced the execution of a definitive commercial offtake agreement between Potássio do Brasil Ltda., a wholly-owned subsidiary of the Company, and Keytrade Fertilizantes Brasil Ltda., the Brazilian subsidiary of Keytrade AG, one of the world’s leading fertilizer trading companies.
- Versus Systems Inc. (NASDAQ:VS) rose 23.2% to $2.62 in pre-market trading.
- Golden Heaven Group Holdings Ltd. (NASDAQ:GDHG) gained 14.3% to $0.4226 in pre-market trading after falling over 8% on Wednesday.
- ETHZilla Corporation (NASDAQ:ETHZ) rose 10.9% to $5.80 in pre-market trading after dipping more than 25% on Wednesday.
- Aegon Ltd. (NYSE:AEG) gained 7.4% to $8.01 in pre-market trading.
- MINISO Group Holding Limited (NASDAQ:MNSO) jumped 5.9% to $22.08 in pre-market trading after reporting second-quarter results.
Losers
- ModivCare Inc (NASDAQ:MODV) shares tumbled 41.1% to $1.09 in pre-market trading. Modivcare filed voluntary Chapter 11 to implement restructuring support agreement backed by more than 90% of first lien lenders and 70% of second lien lender.
- Quhuo Limited (NASDAQ:QH) dipped 32.2% to $0.0703 in pre-market trading after the company announced plans to implement an ADS ratio change from 1:10 to 1:900.
- Greenwave Technology Solutions, Inc. (NASDAQ:GWAV) fell 27.3% to $0.1200 in pre-market trading after the company announced a 1-for-110 reverse stock split.
- Star Fashion Culture Holdings Limited (NASDAQ:STFS) fell 25.2% to $0.3252 in pre-market trading after dipping 79% on Wednesday.
- SU Group Holdings Limited (NASDAQ:SUGP) fell 22.8% to $ 04480 in pre-market trading. SU Group Holdings announced a reverse stock split, share capital increase and share capital alteration.
- Coty Inc. (NYSE:COTY) shares dipped 21.4% to $3.7900 in the pre-market trading session as the company posted mixed fourth-quarter fiscal results after the closing bell on Wednesday. The company posted revenue of $1.25 billion, surpassing Wall Street estimates of $1.20 billion. Coty posted an adjusted loss of 5 cents per share for the quarter, missing analyst expectations for positive earnings of 2 cents per share.
- Elong Power Holding Limited (NASDAQ:ELPW) fell 20.7% to $0.32 in pre-market trading after dipping 88% on Wednesday.
- Shineco, Inc. (NASDAQ:SISI) declined 8.3% to $6.23 in pre-market trading. Shineco shares jumped 37% on Wednesday after the company unveiled its on-chain cell asset tokenization platform.
- Xunlei Limited (NASDAQ:XNET) dipped 5.1% to $6.95 in pre-market trading after declining 7% on Wednesday.
- Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) fell 5.1% to $3.56 in pre-market trading. Rocket Pharmaceuticals shares gained around 29% on Wednesday after the FDA lifted a clinical hold on its pivotal Phase 2 trial for RP-A501.
Now Read This:
Photo via Shutterstock
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.